Cargando…

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats

RATIONALE: Some novel antipsychotics manifest antagonistic activity at serotonin-6 receptors; however, little is known about the role of 5-HT6 receptors in ameliorating sensory gating deficits. OBJECTIVE: We evaluated the effects of the combined administration of the 5-HT6 receptor antagonist SB 271...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fijał, Katarzyna, Popik, Piotr, Nikiforuk, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2013
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889519/ https://www.ncbi.nlm.nih.gov/pubmed/23954911 http://dx.doi.org/10.1007/s00213-013-3234-2

Ejemplares similares

Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats
por: Nikiforuk, Agnieszka, et al.
Publicado: (2013)

Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT(3) and 5-HT(6) Receptor Antagonist with Antipsychotic and Procognitive Properties
por: Zajdel, Paweł, et al.
Publicado: (2021)

The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice
por: Kos, Tomasz, et al.
Publicado: (2010)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor
por: Halberstadt, Adam L., et al.
Publicado: (2009)

Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats
por: Okada, Tsuyoshi, et al.
Publicado: (2020)

Superiority of the Triple-Acting 5-HT(6)R/5-HT(3)R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT(6)R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats
por: Grychowska, Katarzyna, et al.
Publicado: (2023)

Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT(3) Receptors
por: Rammes, Gerhard, et al.
Publicado: (2009)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

The 5-HT(7) receptor antagonist SB 269970 ameliorates corticosterone-induced alterations in 5-HT(7) receptor-mediated modulation of GABAergic transmission in the rat dorsal raphe nucleus
por: Sowa, Joanna, et al.
Publicado: (2018)

Distribution of cells responsive to 5-HT(6) receptor antagonist-induced hypophagia
por: Garfield, Alastair S., et al.
Publicado: (2014)

Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?
por: Spencer, Nick J.
Publicado: (2015)

Role of 5-HT(2A) receptor antagonists in the treatment of insomnia
por: Vanover, Kimberly E, et al.
Publicado: (2010)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

Existence of Brain 5-HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5-HT1A Receptor Recognition
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2017)

Single Administration of HBK-15—a Triple 5-HT(1A), 5-HT(7), and 5-HT(3) Receptor Antagonist—Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone
por: Pytka, Karolina, et al.
Publicado: (2017)

Dual 5-HT(3) and 5-HT(6) Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats
por: Castañé, Anna, et al.
Publicado: (2022)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

Extended N-Arylsulfonylindoles as 5-HT(6) Receptor Antagonists: Design, Synthesis & Biological Evaluation
por: Vera, Gonzalo, et al.
Publicado: (2016)

Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists
por: Gilmore, James, et al.
Publicado: (2018)

Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
por: Murao, Satoshi, et al.
Publicado: (2010)

Targeting the Serotonin 5-HT(7) Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date
por: Nikiforuk, Agnieszka
Publicado: (2015)

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
por: Andrews, Megan, et al.
Publicado: (2018)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022)

5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis
por: Zhou, Chengmao, et al.
Publicado: (2016)

Mismatch negativity generation in the human 5HT(2A) agonist and NMDA antagonist model of psychosis
por: Heekeren, Karsten, et al.
Publicado: (2008)

5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT
por: Sia, Tiong C., et al.
Publicado: (2013)

Reduction of the serotonin 5-HT(1B) and 5-HT(2A) receptor-mediated contraction of human pulmonary artery by the combined 5-HT(1B) receptor antagonist and serotonin transporter inhibitor LY393558
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2020)

Effects of 5-HT(2C), 5-HT(1A) receptor challenges and modafinil on the initiation and persistence of gambling behaviours
por: Humby, Trevor, et al.
Publicado: (2020)

Discovery and Structure-Based Optimization of 6-Bromotryptamine Derivatives as Potential 5-HT(2A) Receptor Antagonists
por: Ding, Lijian, et al.
Publicado: (2015)

Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
por: Li, Xiaojiao, et al.
Publicado: (2021)

Serotonin (5-HT(3)) receptor antagonists for the reduction of symptoms of low anterior resection syndrome
por: Itagaki, Ryohei, et al.
Publicado: (2014)

Nephrotoxicity Evaluation on Cisplatin Combined with 5-HT(3) Receptor Antagonists: A Retrospective Study
por: Kou, Wen, et al.
Publicado: (2018)

Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model
por: Aboulghasemi, Nazanin, et al.
Publicado: (2018)

The Phenoxyalkyltriazine Antagonists for 5-HT(6) Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases
por: Sudoł, Sylwia, et al.
Publicado: (2021)

Selective 5-HT(6) Receptor Ligands (Agonist and Antagonist) Show Different Effects on Antipsychotic Drug-Induced Metabolic Dysfunctions in Rats
por: Partyka, Anna, et al.
Publicado: (2023)

Distribution of 5-HT(3), 5-HT(4), and 5-HT(7) Receptors Along the Human Colon
por: Yaakob, Nor S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u36l2g70bog7rtfdsvlidsnk56